Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities

dc.contributor.authorDietze, Paul
dc.contributor.authorStare, Mark
dc.contributor.authorCogger, Shelley
dc.contributor.authorNambiar, Dhanya
dc.contributor.authorOlsen, Anna
dc.contributor.authorBurns, L
dc.contributor.authorLenton, Simon
dc.date.accessioned2021-07-26T23:44:14Z
dc.date.issued2017
dc.date.updated2020-11-23T10:44:13Z
dc.description.abstractIntroduction and Aims Take-home naloxone (THN) programs targeting people who inject drugs (PWID) have been running in some Australian states and territories since 2012. In this study, we aimed to determine the extent to which PWID in the capital cities of all Australian states and territories are aware of naloxone and THN programs, whether awareness of these programs has changed over time. Design and Methods Data were obtained from cross-sectional surveys of a total of 2088 PWID conducted annually as part of the Illicit Drug Reporting System from 2013 to 2015. Specific questions about THN added to the survey in 2013 allowed assessment of the extent to which sampled PWID were aware of naloxone and its function and THN programs in Australia and whether they had participated in a THN program. These main outcomes were examined over time and across states and territories using a mix of descriptive statistics and logistic regression. Results Over 80% of the sample reported having heard of naloxone across survey years. Less than half of the participants reported having heard of THN programs in 2013 (35%), but this increased to just over (52%) half in 2015 (P < 0.01). Changes over time differed across cities with increases in reports of having heard of THN occurring over time most clearly in those cities with operational THN programs. Discussion and Conclusions Around half of the PWID sampled for this study are aware of THN programs. Further work is needed to ensure widespread awareness of THN programs which should include implementing THN in all Australian states and territories.en_AU
dc.description.sponsorshipThe Illicit Drug Reporting System is funded by the Australian Government Department of Health and Ageing and authors gratefully acknowledge the Victorian Operational Infrastructure Support Program received by the Burnet Institute. SL is supported by funding from the Australian Government under the Drug and Alcohol Program through its core funding of the National Drug Research Instituteen_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0959-5236en_AU
dc.identifier.urihttp://hdl.handle.net/1885/241092
dc.language.isoen_AUen_AU
dc.publisherWileyen_AU
dc.rights© 2017 Australasian Professional Society on Alcohol and other Drugsen_AU
dc.sourceDrug and Alcohol Reviewen_AU
dc.subjectnaloxoneen_AU
dc.subjecttake-home naloxoneen_AU
dc.subjectopioid overdoseen_AU
dc.titleKnowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital citiesen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue4en_AU
local.bibliographicCitation.lastpage463en_AU
local.bibliographicCitation.startpage457en_AU
local.contributor.affiliationDietze, Paul, Burnet Instituteen_AU
local.contributor.affiliationStare , Mark , University of Sydneyen_AU
local.contributor.affiliationCogger, Shelley, Burnet Institute, Centre for Population Healthen_AU
local.contributor.affiliationNambiar , Dhanya , Centre for Research Excellence into Injecting Drug Use and Burnet Instituteen_AU
local.contributor.affiliationOlsen, Anna, College of Health and Medicine, ANUen_AU
local.contributor.affiliationBurns, L, University of New South Walesen_AU
local.contributor.affiliationLenton, Simon, National Drug Research Instituteen_AU
local.contributor.authoruidOlsen, Anna, u4017240en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor111506 - Toxicology (incl. Clinical Toxicology)en_AU
local.identifier.absfor111706 - Epidemiologyen_AU
local.identifier.absfor111711 - Health Information Systems (incl. Surveillance)en_AU
local.identifier.absseo920204 - Evaluation of Health Outcomesen_AU
local.identifier.absseo920409 - Injury Controlen_AU
local.identifier.absseo929999 - Health not elsewhere classifieden_AU
local.identifier.ariespublicationu4492120xPUB208en_AU
local.identifier.citationvolume37en_AU
local.identifier.doi10.1111/dar.12644en_AU
local.identifier.scopusID2-s2.0-85038882734
local.publisher.urlhttps://www.wiley.com/en-gben_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Dietze_Knowledge_of_naloxone_and_2017.pdf
Size:
203.57 KB
Format:
Adobe Portable Document Format